Answer
St John's wort should be avoided during imatinib treatment because it induces CYP3A4 and may significantly reduce exposure to Glivec (imatinib), potentially increasing the risk of treatment failure.
Sources for this answer
- GLIVEC film-coated tabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 41Document updated
Sources checked